Active Pharmaceutical Ingredient

Granisetron

Also known as: Kytril

CAS: 109889-09-0 5-HT3 Receptor Antagonist / Antiemetic IP / BP / EP / USP GMP Certified Aurangabad, Maharashtra, India
Granisetron API — Mediocon Inc
Granisetron — Pharmaceutical Grade API

Product Overview

CAS No: 109889-09-0  |  MF: C18H24N4O  |  MW: 312.41 g/mol

Granisetron is a selective 5-HT3 receptor antagonist antiemetic used to prevent nausea and vomiting caused by chemotherapy, radiotherapy, and post-operative recovery. Mediocon Inc supplies pharmaceutical-grade Granisetron API.

Key Features

  • Selective 5-HT3 receptor antagonist
  • Prevention of chemotherapy-induced nausea
  • IP/BP/EP/USP compliant
  • Full CoA and MSDS documentation

Applications

  • Chemotherapy-induced nausea and vomiting (CINV)
  • Radiotherapy-induced emesis
  • Post-operative nausea and vomiting (PONV)
  • Oncology supportive care

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameGranisetron
Also Known AsKytril
CAS Number109889-09-0
Molecular FormulaC18H24N4O
Molecular Weight312.41 g/mol
Category5-HT3 Receptor Antagonist / Antiemetic
AppearanceWhite to off-white crystalline powder
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
Assay≥98.0% (as per pharmacopoeia)
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?